Pharmaceutical Peptides

KPV Tripeptide

KPV (Lys-Pro-Val) is a tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). Despite its small size, KPV retains the potent anti-inflammatory properties of the parent hormone through interaction with melanocortin receptors and direct inhibition of NF-κB inflammatory signaling pathways. Research demonstrates KPV's efficacy in reducing intestinal inflammation (relevant to IBD/Crohn's disease), skin inflammation, and wound healing acceleration. Its small molecular size enables multiple delivery routes including oral, topical, and injectable. KPV is experiencing rapidly growing demand in the peptide wholesale market for both pharmaceutical research and dermatological applications.